Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Revenue of AbbVie's Humira 2011-2018

AbbVie's revenue from top product Humira from 2011 to 2018 (in million U.S. dollars)

by Matej Mikulic, last edited Feb 28, 2019
Revenue of AbbVie's Humira 2011-2018 This statistic illustrates the revenue of pharmaceutical product Humira from 2011 to 2018. In 2018, AbbVie's top product generated nearly 20 billion U.S. dollars of revenue. Abbot Laboratories was a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois. In January 2013, Abbott was separated into two companies: Abbott and AbbVie. Abbott is now specialized on medical products, while AbbVie is responsible for research-based pharmaceuticals.
Abbvie's top product Humira

AbbVie’s Humira has increased its revenue from 2011 to 2017, generating 7.9 billion U.S. dollars in 2011 and nearly 20 billion U.S. dollars in 2018. Humira is expected to continue its success in the near future. It is projected to maintain similar high revenues until 2024 worldwide. In the United States, AbbVie expended 410 million U.S. dollars on advertising for Humira in 2017.

Adalimumab is marketed as Humira, a biotech pharmaceutical product. The name “Humira” is derived from “human monoclonal antibody in rheumatoid arthritis”. The inhibiting anti-inflammatory drug acts by inhibiting the activation of tumor necrosis factor-alpha (TNF) which can downregulate inflammation caused by autoimmune diseases. For example, it can be used for rheumatoid arthiritis which attacks the joints and can also impact tissues and organs. Humira can be also be used for diseases such as Plaque psoriasis and Crohn’s disease. Monthly purchases of Humira can cost some 2,700 U.S. dollars, as of 2015.
Show more

AbbVie's revenue from top product Humira from 2011 to 2018 (in million U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
AbbVie
AbbVie

All Information
in one Presentation

AbbVie

Everything On "AbbVie" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Pharmaceutical brands: Humira (AbbVie)"
  • Overview
  • Drug prices and consumer behavior
  • Advertising expenditures
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: You might find this interesting as well
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.